Press
Press & News
Announcements, press releases, and organizational milestones from Amavita Research.
Recent press releases and news announcements from Amavita Research. For media inquiries, contact research@amavita.health.
2026 Announcements
13 May 2026
Coronary Stent at Miami-Dade County's First Cardiovascular ASC
Amavita Research performs a coronary stent procedure at Amavita's Kendall ASC — the first cardiovascular ambulatory surgery center in Miami-Dade County, with same-day discharge — led by Dr. Pedro Martinez-Clark.
13 May 2026
Amavita Research Achieves 2026 IAOCR GCSA Recertification
Independent assessment confirms continued operational excellence across all 7 modules of the GCSA V5 2024 standard. Valid through 28 February 2027.
Media contact
- For media inquiries: research@amavita.health
- Phone: (786) 703-5941
- Address: 100 NW 170 Street, Suite 305, North Miami Beach, FL 33169, USA
About Amavita Research
Amavita Research Services, LLC is a Miami-based cardiovascular clinical research site founded in 2017, operating inside amavita Heart and Vascular Health® — the largest independent cardiovascular practice in South Florida. IAOCR GCSA recertified May 2026 (valid through February 2027). Sister organization to bioaccess®, the Latin America first-in-human CRO. Site capabilities: https://www.amavitaresearch.com/capabilities. Trial services: https://www.amavitaresearch.com/trial-services.